Cargando…

Management of familial benign chronic pemphigus

Benign familial chronic pemphigus or Hailey–Hailey disease is caused by an autosomal dominant mutation in the ATP2C1 gene leading to suprabasilar acantholysis. The disease most commonly affects intertriginous areas symmetrically. The chronic nature of the disease and multiple recurrences make the di...

Descripción completa

Detalles Bibliográficos
Autores principales: Arora, Harleen, Bray, Fleta N, Cervantes, Jessica, Falto Aizpurua, Leyre A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027951/
https://www.ncbi.nlm.nih.gov/pubmed/27695354
http://dx.doi.org/10.2147/CCID.S89483
_version_ 1782454312698380288
author Arora, Harleen
Bray, Fleta N
Cervantes, Jessica
Falto Aizpurua, Leyre A
author_facet Arora, Harleen
Bray, Fleta N
Cervantes, Jessica
Falto Aizpurua, Leyre A
author_sort Arora, Harleen
collection PubMed
description Benign familial chronic pemphigus or Hailey–Hailey disease is caused by an autosomal dominant mutation in the ATP2C1 gene leading to suprabasilar acantholysis. The disease most commonly affects intertriginous areas symmetrically. The chronic nature of the disease and multiple recurrences make the disease bothersome for patients and a treatment challenge for physicians. Treatments include topical and/or systemic agents and surgery including laser. This review summarizes the available treatment options.
format Online
Article
Text
id pubmed-5027951
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-50279512016-09-30 Management of familial benign chronic pemphigus Arora, Harleen Bray, Fleta N Cervantes, Jessica Falto Aizpurua, Leyre A Clin Cosmet Investig Dermatol Review Benign familial chronic pemphigus or Hailey–Hailey disease is caused by an autosomal dominant mutation in the ATP2C1 gene leading to suprabasilar acantholysis. The disease most commonly affects intertriginous areas symmetrically. The chronic nature of the disease and multiple recurrences make the disease bothersome for patients and a treatment challenge for physicians. Treatments include topical and/or systemic agents and surgery including laser. This review summarizes the available treatment options. Dove Medical Press 2016-09-14 /pmc/articles/PMC5027951/ /pubmed/27695354 http://dx.doi.org/10.2147/CCID.S89483 Text en © 2016 Arora et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Review
Arora, Harleen
Bray, Fleta N
Cervantes, Jessica
Falto Aizpurua, Leyre A
Management of familial benign chronic pemphigus
title Management of familial benign chronic pemphigus
title_full Management of familial benign chronic pemphigus
title_fullStr Management of familial benign chronic pemphigus
title_full_unstemmed Management of familial benign chronic pemphigus
title_short Management of familial benign chronic pemphigus
title_sort management of familial benign chronic pemphigus
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027951/
https://www.ncbi.nlm.nih.gov/pubmed/27695354
http://dx.doi.org/10.2147/CCID.S89483
work_keys_str_mv AT aroraharleen managementoffamilialbenignchronicpemphigus
AT brayfletan managementoffamilialbenignchronicpemphigus
AT cervantesjessica managementoffamilialbenignchronicpemphigus
AT faltoaizpurualeyrea managementoffamilialbenignchronicpemphigus